Halofuginone targets Serine/Glycine synthesis to reverse epidermal growth factor receptor Tyrosine Kinase inhibitor resistance in lung adenocarcinoma
HF is a promising natural product for overcoming NSCLC resistance to third-generation epidermal growth factor receptors-TKIs.
Authors
- Yongping Li (ORCID: https://orcid.org/0000-0002-9001-8524)
- Dawei Tang (ORCID: https://orcid.org/0009-0002-7587-6894)
- Pei Zhang (ORCID: https://orcid.org/0009-0003-4394-970X)
- Zuojie Jiang (ORCID: https://orcid.org/0000-0002-2602-7565)
- Fangtian Fan (ORCID: https://orcid.org/0000-0002-6189-1770)
- Yunlei Fan
- Shanshan Li (ORCID: https://orcid.org/0000-0001-6443-958X)
- Peipei Liu (ORCID: https://orcid.org/0000-0002-9097-3425)
- Juan Zhu
- Mengxiao Zhang (ORCID: https://orcid.org/0000-0002-6274-0384)
- Zixuan Meng
- Yuehua Han
- Shiyao Liu (ORCID: https://orcid.org/0009-0009-6335-1055)
- Haibo Liu (ORCID: https://orcid.org/0000-0002-4213-2883)
Institutions
- Bengbu Medical College (CN)
Publication Details
- Journal
- Phytomedicine
- Published
- 2025-04-26
- DOI
- https://doi.org/10.1016/j.phymed.2025.156788
- Citations
- 2
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.87